Table 2 The downstream effects of the upstream regulators from the comparison of m vs. p.
From: Combating viral contaminants in CHO cells by engineering innate immunity
Virus | Consis-tency score*a | Total nodes (TF, TG, BP) | Transcription factors (TF)*b | Target gene (TG)*c | Biological Process (BP)*d | Relations*e |
|---|---|---|---|---|---|---|
30 h | 5.82 | 21 (5, 13, 3) | STAT1, IRF3, IRF5, IRF7, NFATC2 | CASP1, CXCL10, DDX58, EIF2AK2, IFIH1, IL15, ISG15, Mx1/Mx2, OASL2, PELI1, PML, SOCS1, TNFSF10 | Inhibit Replication of virus. Activate Activation of phagocytes; Apoptosis of antigen presenting cells. | 6/15 (40%) |
54 h | 22.47 | 48 (7.29.12) | STAT1, IRF3, IRF5, IRF7, NFATC2, TRIM24, NCOA2 | BST2, C3, CASP1, CXCL10, DDX58, EGR2, EIF2AK2, GBP2, IFIH1, IFIT1B, IFIT2, IFITM3 (IITMP3), Igtp, IL15, ISG15, Mx1/Mx2, MYC, OASL2, PML, PSMB10, PSMB8, PSME2, PTGS2, SPP1, STAT2, TAP1, TLR3, TNFSF10, TRAFD1 | Inhibit Replication of virus; Infection by RNA virus; Infection of central nervous system. Activate Antiviral response; Clearance of virus; Immune response of antigen presenting cells; Immune response of phagocytes; Cytotoxicity of leukocytes; Function of leukocytes; Infiltration by T lymphocytes; Quantity of MHC Class I of cell surface; Cell death of myeloid cells. | 21/84 (25%) |
78 h | 27.80 | 30 (8, 14, 8) | STAT1, IRF5, NFATC2, NR3C1, PPARD, ZBTB16, CDKN2A, EBF1 | C3, CCL2, CCL7, CD36, CXCL10, CXCL9, DDX58, EIF2AK2, ISG15, MYC, THBS1, TLR3, TNFSF10, VEGFA | Activate Activation of macrophages; Apoptosis of myeloid cells; Cell movement of T lymphocytes; Cellular infiltration by leukocytes; Damage of lung; Recruitment of leukocytes; Response of myeloid cells; Response of phagocytes. | 11/64 (17%) |
78 h | 7.56 | 12 (2, 7, 3) | CDKN2A, ZBTB16 | C3, CCL2, CCL7, CXCL10, CXCL9, MYC, VEGFA | Activate Cell movement of T lymphocytes; Recruitment of leukocytes; Survival of organism. | 1/6 (17%) |